ANROWS, June 2020 Crossing the line: Lived experience of sexual violence among trans women of colour from culturally and linguistically diverse backgrounds in Australia This research set out to increase understanding of the lived experience of being a trans woman of colour living in Australia, in relation to gender transitioning and experiences of sexual violence. Using a large comparative...
Kota, K.K., Salazar, L.F., Culbreth, R.E. et al. Psychosocial mediators of perceived stigma and suicidal ideation among transgender women. BMC Public Health 20, 125 (2020). Abstract Background Transgender women (TGW) in the U.S. experience high rates of stigma, depression, and elevated rates of suicide. This study examined correlates of suicidal ideation and estimated the conditional indirect...
Life satisfaction and mental health among transgender students in Norway Anderssen, N., Sivertsen, B., Lønning, K.J. et al. BMC Public Health 20, 138 (2020) Background Social attitudes to transgender persons and other gender minorities vary around the world, and in many cultures, prejudices and social stigma are common. Consequently, transgender persons face challenges related to discrimination...
Med J Aust. 2019 Aug 29. doi: 10.5694/mja2.50322. [Epub ahead of print] Abstract Objectives To estimate rates of HIV infection, chlamydia, gonorrhoea, and infectious syphilis in transgender men and women in Australia; to compare these rates with those for cisgender people. Design Cross‐sectional, comparative analysis of de‐identified health data. Setting, participants We analysed data for 1260...
Transgend Health. 2018; 3(1): 239–250 Abstract: Trans women are a key, yet under-researched, population in the HIV epidemic. However, there remains a paucity of data on the health and wellbeing of trans women at risk of, or living with, HIV in the United Kingdom. This article provides a narrative review of key empirical research into HIV among trans women. In an effort to explore individual and...
aidsmap/nam, November 9th 2018 A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells...